Clinical Trials Logo

Filter by:
NCT ID: NCT00045760 Completed - Sepsis Clinical Trials

The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis

Start date: September 2002
Phase: Phase 4
Study type: Interventional

Severe sepsis is defined as a systemic inflammatory response syndrome that results from infection and is associated with acute organ dysfunction. It usually results from bacterial infections, but it may occur in response to other pathogens, such as fungi, viruses, and parasites.

NCT ID: NCT00044421 Completed - Diabetes Mellitus Clinical Trials

Treatment of Peripheral Neuropathy in Patients With Diabetes

Start date: July 2002
Phase: Phase 3
Study type: Interventional

The purpose of this protocol is to determine if an investigational drug is effective in treating nerve malfunction in diabetes.

NCT ID: NCT00044395 Completed - Clinical trials for Diabetic Neuropathies

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

Start date: July 2002
Phase: Phase 3
Study type: Interventional

The purpose of this protocol is to determine if an investigational drug is effective in treating nerve malfunction in diabetes.

NCT ID: NCT00041301 Completed - Prostate Cancer Clinical Trials

Assessing Quality of Life of Patients With Prostate Cancer

Start date: March 2002
Phase: N/A
Study type: Observational

RATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate and long-term effects of the treatment on these patients. PURPOSE: Clinical trial to study the effectiveness of two questionnaires in assessing quality of life of patients who have prostate cancer.

NCT ID: NCT00041236 Completed - Sarcoma Clinical Trials

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Start date: May 2002
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of exatecan mesylate in treating patients who have advanced soft tissue sarcoma.

NCT ID: NCT00038467 Completed - Breast Neoplasms Clinical Trials

Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer

IES
Start date: February 1998
Phase: Phase 3
Study type: Interventional

To compare the sequential administration of exemestane with administration of further tamoxifen until 5 years in postmenopausal women with operable breast cancer who have already received 2-3 years of adjuvant tamoxifen, in terms of disease-free survival (DFS), overall survival (OS), incidence of contralateral breast cancer and long-term tolerability.

NCT ID: NCT00036868 Completed - Breast Cancer Clinical Trials

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

Start date: February 2002
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy such as cyclophosphamide, methotrexate, and fluorouracil use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies, such as trastuzumab, can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Combining chemotherapy with trastuzumab may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining combination chemotherapy with trastuzumab in treating women who have metastatic breast cancer.

NCT ID: NCT00030784 Completed - Sarcoma Clinical Trials

Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Start date: November 2001
Phase: Phase 1
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining liposomal doxorubicin with ifosfamide in treating patients who have advanced or metastatic soft tissue sarcoma.

NCT ID: NCT00029822 Completed - Clinical trials for Prostatic Hyperplasia

Clinical Trial in Males With BPH (Enlarged Prostate)

Start date: May 2001
Phase: Phase 3
Study type: Interventional

A study to determine the effect on prevention of Acute Urinary Retention (inability to urinate) in males with an enlarged prostate, also known as BPH. - Free study-related medical care provided.

NCT ID: NCT00025649 Completed - Neuroblastoma Clinical Trials

Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma

Start date: July 1999
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell or bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy given before surgery followed by peripheral stem cell or bone marrow transplantation in treating infants who have newly diagnosed neuroblastoma.